Ana Maria
Hurtado Lopez
Hospital Morales Meseguer
Murcia, EspañaPublications in collaboration with researchers from Hospital Morales Meseguer (8)
2023
-
NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition
British Journal of Haematology, Vol. 201, Núm. 3, pp. 470-479
2020
-
Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach
OncoImmunology, Vol. 9, Núm. 1
-
Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia
Haematologica, Vol. 105, Núm. 1, pp. 112-123
2019
-
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation
Annals of Hematology, Vol. 98, Núm. 9, pp. 2151-2162
2018
-
An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups
International Journal of Laboratory Hematology, Vol. 40, Núm. 5, pp. 549-555
-
Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes
Haematologica
-
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia
British Journal of Haematology, Vol. 182, Núm. 3, pp. 373-383
2015
-
Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
Blood Cancer Journal, Vol. 5